Microplastics and Nanoplastics in the Human Intestine: A Review of Health Implications and Possible Dietary Interventions.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and early human evidence
PubMed 41903888 · doi:10.1016/j.advnut.2026.100624
What was done
This review synthesized published literature evaluating how microplastics and nanoplastics (MNPs) interact with the human gastrointestinal system. The authors assessed mechanisms including intestinal barrier disruption, particle uptake, systemic translocation, biotransformation, and gut microbiota dysbiosis, as well as dietary patterns that might modify exposure and biological response.
What was found
The abstract reports no numerical data or effect sizes. Experimental evidence indicates that particle size, polymer type, and surface characteristics govern intestinal uptake and toxicity, with smaller particles demonstrating higher systemic translocation. The review highlights preliminary associations between MNP exposure and conditions such as inflammatory bowel disease and metabolic disturbances, and suggests that minimizing packaged foods while consuming fiber, antioxidants, and probiotics may mitigate oxidative and inflammatory damage.
Why it matters
It organizes the mechanistic pathways of ingested plastic particle toxicity and connects them to actionable dietary hypotheses, framing priorities for standardized human exposure studies.
Limits
The abstract provides no sample sizes or quantitative metrics. Evidence in humans is limited and unstandardized, relying primarily on mechanistic and preclinical extrapolation. The proposed dietary interventions represent theoretical mitigation strategies rather than outcomes tested in controlled trials.
Cited by
- supports Larger microplastics are poorly absorbed through gut epithelial cells and are excreted in feces, whereas smaller particles are more readily absorbed.